Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Are Prescription Drugs Next On Amazon’s Agenda?

By Mike Botta | October 10, 2017

The investment community was abuzz Tuesday following word that Amazon might be considering a move into the prescription drug business.

Speculation about such a move began surfacing around the time Amazon acquired Whole Foods in June, but analysts at investment firm Leerink fueled the flames on Friday when they commented that Amazon “almost certainly” will get into prescription drugs within a couple of years.

Critics countered that, while it’s hard to rule out Amazon’s will to disrupt another part of the business environment, the online service hasn’t fared as well when dealing with highly regulated industries, including alcohol distribution.

 “The highly regulated drug business has never been particularly transparent,” journalist Emma Court wrote in a MarketWatch report on the subject Tuesday. “At best, U.S. drug pricing is complex; at worst, it’s dysfunctional.”

Still, pharmacy benefit management and mail order firms like Express Scripts could become particularly vulnerable if Amazon jumps into the arena. Some speculate that the powerful online retailer, with its robust cash, may even look to enter into the space via acquisition.

Following last Friday’s Leerink report, Express Scripts stock fell 2.5 percent, while the CVS and Walgreens chains fell about 5 percent, according to a CNN Money report, which noted that all three stocks fell further in trading on Monday, even as Amazon and the major stock markets were up.

In midday trading Tuesday, Express Scripts and Walgreens were down again, while CVS stock was up slightly.

In, perhaps, unrelated news, Express Scripts announced Tuesday that it is buying eviCore for $3.6 billion. The Bluffton, SC-based eviCore contracts with health plans and commercial clients to manage health care services.

For its part, Amazon said it had no comment on the speculative market reports.

(Sources: CNN Money; MarketWatch)

Related Articles Read More >

Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE